Does the polymorphism 677C-T of the 5,10-methylenetetrahydrofolate reductase gene contribute to homocysteine-related vascular disease?

[1]  K. Kawazoe,et al.  Genetic polymorphism of 5,10‐methylenetetrahydrofolate increases risk of myocardial infarction and is correlated to elevated levels of homocysteine in the Japanese general population , 2000, Coronary artery disease.

[2]  J. Wainscoat,et al.  Factor V Leiden and Thermolabile Methylenetetrahydrofolate Reductase in Extreme Old Age , 1997, Thrombosis and Haemostasis.

[3]  F. Costa,et al.  The Mutation Ala677→Val in the Methylene Tetrahydrofolate Reductase Gene: A Risk Factor for Arterial Disease and Venous Thrombosis , 1997, Thrombosis and Haemostasis.

[4]  Y. Yazaki,et al.  Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. , 1997, Circulation.

[5]  KojiMaemura,et al.  Genetic Polymorphism of 5,10-Methylenetetrahydrofolate Reductase (MTHFR) as a Risk Factor for Coronary Artery Disease , 1997 .

[6]  S. Vasikaran,et al.  Methylenetetrahydrofolate reductase gene and coronary artery disease. , 1997, Circulation.

[7]  A. Marian,et al.  A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction. , 1997, Atherosclerosis.

[8]  J. Kastelein,et al.  Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. , 1997, Circulation.

[9]  L. Taylor,et al.  Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. , 1996, Circulation.

[10]  R. Banerjee,et al.  Defects in human methionine synthase in cblG patients. , 1996, Human molecular genetics.

[11]  M. Margaglione,et al.  Elevated total plasma homocysteine and 677C-->T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease. , 1996, American journal of human genetics.

[12]  K. Kario,et al.  A common mutation in methylenetetrahydrofolate reductase gene among the Japanese population , 1996, Japanese Journal of Human Genetics.

[13]  N. Iwai,et al.  Molecular variant of 5,10-methylenetetrahydrofolate reductase is a risk factor of ischemic heart disease in the Japanese population. , 1996, Atherosclerosis.

[14]  T. Goosen,et al.  Molecular Genetic Analysis , 1996 .

[15]  I. Rosenberg,et al.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. , 1996, Circulation.

[16]  A. Motulsky.  Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. , 1996, American journal of human genetics.

[17]  P. Frosst,et al.  Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. , 1996, American journal of human genetics.

[18]  D C Shields,et al.  A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. , 1995, QJM : monthly journal of the Association of Physicians.

[19]  H. Blom,et al.  Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? , 1995, The Lancet.

[20]  R. D'Agostino,et al.  Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. , 1995, The New England journal of medicine.

[21]  M. Stampfer,et al.  Can lowering homocysteine levels reduce cardiovascular risk? , 1995, The New England journal of medicine.

[22]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[23]  H. Blom,et al.  Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. , 1995, American journal of human genetics.

[24]  R. Matthews,et al.  Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification , 1994, Nature Genetics.

[25]  H. Blom,et al.  Treatment of mild hyperhomocysteinemia in vascular disease patients. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[26]  J. Saudubray,et al.  Methylenetetrahydrofolate reductase deficiency: Prenatal diagnosis and family studies , 1994, Prenatal diagnosis.

[27]  P. Wong,et al.  Thermolabile Defect of Methylenetetrahydrofolate Reductase in Coronary Artery Disease , 1993, Circulation.

[28]  W. Willett,et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.

[29]  J. Vallat,et al.  Homocystinuria due to 5,10‐methylenetetra‐hydrofolate reductase deficiency revealed by stroke in adult siblings , 1991, Neurology.

[30]  R. Clarke,et al.  Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.

[31]  M. Norusis,et al.  Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. , 1991, American journal of human genetics.

[32]  P. Wilson,et al.  Plasma homocyst(e)ine levels in men with premature coronary artery disease. , 1990, Journal of the American College of Cardiology.

[33]  P. Kamoun,et al.  Rapid determination of total homocysteine in plasma. , 1989, Clinical chemistry.

[34]  G. Boers,et al.  Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.

[35]  P. Ueland,et al.  Radioenzymic determination of homocysteine in plasma and urine. , 1985, Clinical chemistry.